Navigation Links
New Treatment For Skin Cancer Using Body's own Immune System

Researchers have claimed that body's immune system can be used as an effective weapon against the most serious type of skin cancer. //Patients whose immune system was enhanced by drugs lived longer and their malignant melanomas also reduced noticeably.

Two research teams in the U.S. were able to improvise the immune system's attack on cancer cells. Both these studies were presented at a conference on cancer research at Prague.

Nearly 8000 people in Britain are affected by malignant melanoma every year and it claimed 1,777 lives in 2004. After diagnosis at the most critical stage, the average life expectancy is around 9 months. Treatment involves surgery or high doses of chemotherapy. Though the tumour size can be reduced but recurrence cannot be prevented.

The amount of activated T-cells that attack the foreign bodies is controlled by regulatory T-cells (Tregs).

Jason Chesney, of the University of Louisville, Kentucky carried out a study on his patients. He gave a combination of diphtheria toxin and interleukin-2 to 7 patients who had advanced form of skin cancer. The 2 were used to eliminate Tregs. The tumours either reduced in size or remained stable in 5 of the patients. All 7 of them are still alive after a year of treatment.

In another study, Jeffrey Weber, of the University of Southern California in Los Angeles, succeeded in blocking a protein on Treg. 25 patients were given antibodies to suppress Tregs. Of them 3 are free of cancer and 24 of them are still alive after nearly one and half years.

Dr Chesney told the cancer conference: 'From the results, we conclude that depleting Treg cells in patients with melanoma may allow the immune system to be activated successfully to kill cancer cells.

'These patients have survived longer than the median average life expectancy of a patient with stage four melanoma.' He added: 'We also believe that, in the future, immunotherapies that depend on de pleting Treg cells may prove to be useful in all types of cancer.'

Anna Pavlick, director of the melanoma programme at New York University, said, 'The research is a landmark study.' However, boosting of immune system does increase the risk of diseases like hepatitis, colitis and dermatitis.

Further studies are required to validate the findings of these two studies. If it woks well, the treatment would be extended to other forms of cancer involving Tregs.
GYT
'"/>




Related medicine news :

1. Advances in Treatment of Cataracts
2. Recommendations for Treatment of Blood Pressue
3. Treatment for Menieres disease
4. Treatment for pre-menstrual syndrome is ineffective
5. Better Treatment for obesity
6. Gene Treatment for Heart Disease
7. More People Seeking Treatment for Depression
8. Focused Treatment For Childhood Cancer
9. Inadequate Drug Treatment For Youth
10. FDA Approves New surgery Treatment for Farsightedness
11. Treatment of antibiotics ineffectual in bronchitis
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/17/2017)... ... ... Smiles by Seese is a comprehensive family dental practice located ... practice as a skilled and highly credentialed dentist who is qualified to perform a ... all ages with excellence in general, restorative, and cosmetic dentistry . Their services ...
(Date:2/17/2017)... ... February 17, 2017 , ... Wells Pharmacy Network ... prescribing of controlled and non-controlled substances plus the ability to manage orders on ... United States now accept electronic prescriptions, according to the Office of the National ...
(Date:2/17/2017)... ... February 17, 2017 , ... ... Dr. Carol Francis' goals for each and every seminar, session and class ... will demonstrate five different brainwave tools which help energize creativity, focus mental functions, ...
(Date:2/17/2017)... ... February 17, 2017 , ... Access today announced that it ... Fla., February 19-23. Visitors to the company’s booth (#1778) will be the first ... signatures solution in healthcare . , Since it first introduced Electronic Signature ...
(Date:2/17/2017)... ... February 17, 2017 , ... Pharmica Consulting ... on all facets of clinical trial planning and management. Pharmica discussed the importance ... more. In addition, attendees stopping by Pharmica’s booth were able to demo its ...
Breaking Medicine News(10 mins):
(Date:2/17/2017)... -- Perrigo Company plc (NYSE, TASE: PRGO) today announced it has ... for hydrocodone bitartrate and homatropine methylbromide oral solution (syrup), 5 ... and homatropine methylbromide oral solution (syrup), 5 mg/1.5 mg per ... in adults and children 6 years of age and older. ... approximately $16 million.   ...
(Date:2/17/2017)... 2017   Risperdal lawsuits involving gynecomastia (male breast ... use of the atypical antipsychotic medication continue to move ... of Common Pleas, where the state,s Risperdal docket has ... a notice posted on the Court,s website , ... March 9, 2017 at 11:00 a.m. (In Re: Risperdal ...
(Date:2/17/2017)... , Feb. 17, 2017 /PRNewswire/ ... offerings at the  2017 HIMSS Conference & Exhibition (HIMSS17 ... PHIA), a global leader in ... range of population health management, acute ... fully integrated in a highly secure, ...
Breaking Medicine Technology: